Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin plus Paclitaxel with Radiotherapy for Uterine Serous Papillary Cancer
NCT00147680Phase 2Completed
- Sponsor
- Queensland Centre for Gynaecological Cancer Research
- Start
- Sep 2004
- Primary completion
- Jun 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin in uterine papillary serous carcinoma (UPSC), sponsored by Queensland Centre for Gynaecological Cancer Research. Started Sep 2004; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
uterine papillary serous carcinoma (UPSC)
Beyond the preview
Go deeper on NCT00147680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147680.